Drug-eluting nanofibrous wound dressings composed of polycaprolactone and gelatin augment diabetic wounds healing via reducing oxidative stress and inflammation: An in vitro and in vivo study
Restricted accessResearch articleFirst published online March, 2024
Drug-eluting nanofibrous wound dressings composed of polycaprolactone and gelatin augment diabetic wounds healing via reducing oxidative stress and inflammation: An in vitro and in vivo study
Diabetes is a prevalent medical condition that often leads to complications, including diabetic wounds that can have serious consequences such as infections, amputations, and death. In the current research, lodoxamide was loaded into electrospun polycaprolacton/gelatin scaffolds In order to improve wound healing in a rat model. Our developed dressings were characterized in vitro using various methods and then applied on a rat model of excisional wound. Study showed that the dressings were not toxic and promoted migration potential of skin-derived fibroblast cells. Wound healing study showed that lodoxamide-loaded dressings had markedly higher healing potential than other scaffolds and augmented collagen deposition and epithelialization. Gene expression studies showed that TNF-α, glutathione peroxidase, and superoxide dismutase genes were significantly downregulated by lodoxamide-loaded scaffolds.
DengLDuCSongP, et al. The role of oxidative stress and antioxidants in diabetic wound healing. Oxid Med Cell Longev2021; 2021: 8852759.
2.
BurgessJLWyantWAAbdo AbujamraB, et al. Diabetic wound-healing science. Medicina2021; 57: 1072.
3.
ShaoZYinTJiangJ, et al. Wound microenvironment self-adaptive hydrogel with efficient angiogenesis for promoting diabetic wound healing. Bioact Mater2023; 20: 561–573.
4.
LiuJQuMWangC, et al. A dual-cross-linked hydrogel patch for promoting diabetic wound healing. Small2022; 18: 2106172.
5.
ChenJChenDChenJ, et al. An all-in-one CO gas therapy-based hydrogel dressing with sustained insulin release, anti-oxidative stress, antibacterial, and anti-inflammatory capabilities for infected diabetic wounds. Acta Biomater2022; 146: 49–65.
6.
LinQLiKChenY, et al. Oxidative stress in diabetic peripheral neuropathy: pathway and mechanism-based treatment. Mol Neurobiol2023; 60(8): 4574–4594.
7.
XuZHanSGuZ, et al. Advances and impact of antioxidant hydrogel in chronic wound healing. Adv Healthc Mater2020; 9: e1901502.
8.
ZhangYLiMWangY, et al. Exosome/metformin-loaded self-healing conductive hydrogel rescues microvascular dysfunction and promotes chronic diabetic wound healing by inhibiting mitochondrial fission. Bioact Mater2023; 26: 323–336.
9.
LiuYLiTHanY, et al. Recent development of electrospun wound dressing. Curr Opin Biomed Eng2021; 17: 100247.
10.
AdamuBFGaoJJhatialAK, et al. A review of medicinal plant-based bioactive electrospun nano fibrous wound dressings. Mater Des2021; 209: 109942.
11.
YangJWangKYuD-G, et al. Electrospun Janus nanofibers loaded with a drug and inorganic nanoparticles as an effective antibacterial wound dressing. Mater Sci Eng C Mater Biol Appl2020; 111: 110805.
12.
HuangCXuXFuJ, et al. Recent progress in electrospun polyacrylonitrile nanofiber-based wound dressing. Polymers2022; 14: 3266.
13.
Naseri-NosarMFarzamfarSSahrapeymaH, et al. Cerium oxide nanoparticle-containing poly (ε-caprolactone)/gelatin electrospun film as a potential wound dressing material: in vitro and in vivo evaluation. Mater Sci Eng C Mater Biol Appl2017; 81: 366–372.
14.
FarzamfarSNaseri-NosarMSamadianH, et al. Taurine-loaded poly (ε-caprolactone)/gelatin electrospun mat as a potential wound dressing material: in vitro and in vivo evaluation. J Bioact Compat Polym2018; 33: 282–294.
15.
LeonardiABorghesanFAvarelloA, et al. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol1997; 81: 23–26.
16.
MacKenzieAECaltabianoGKentTC, et al. The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35. Mol Pharmacol2014; 85: 91–104.
17.
JollySAbramsGRomsonJ, et al. Effects of lodoxamide on ischemic reperfused myocardium. J Cardiovasc Pharmacol1982; 4: 441–448.
18.
DoostmohammadiMForootanfarHRamakrishnaS. Regenerative medicine and drug delivery: progress via electrospun biomaterials. Mater Sci Eng C Mater Biol Appl2020; 109: 110521.
19.
MousaviS-MNejadZMHashemiSA, et al. Bioactive agent-loaded electrospun nanofiber membranes for accelerating healing process: a review. Membranes2021; 11: 702.
20.
SamadianHZamiriSEhteramiA, et al. Electrospun cellulose acetate/gelatin nanofibrous wound dressing containing berberine for diabetic foot ulcer healing: in vitro and in vivo studies. Sci Rep2020; 10: 1–12.
21.
FahimiradSAjalloueianF. Naturally-derived electrospun wound dressings for target delivery of bio-active agents. Int J Pharm2019; 566: 307–328.
22.
ChenKHuHZengY, et al. Recent advances in electrospun nanofibers for wound dressing. Eur Polym J2022; 178: 111490.
23.
PakolpakçılAOsmanBGöktalayG, et al. Design and in vivo evaluation of alginate-based pH-sensing electrospun wound dressing containing anthocyanins. J Polym Res2021; 28: 1–13.
DwivediRKumarSPandeyR, et al. Polycaprolactone as biomaterial for bone scaffolds: review of literature. J Oral Biol Craniofac Res2020; 10: 381–388.
26.
EssumanVNtim-AmponsahCVemugantiG, et al. A prospective trial of postoperative Lodoxamide (Alomide) on pterygium recurrence. Ghana Med J2015; 49: 239–244.
27.
CaloriIRBragaGda Costa Carvalho de JesusP, et al. Polymer scaffolds as drug delivery systems. Eur Polym J2020; 129: 109621.
28.
KondiahPJKondiahPPChoonaraYE, et al. A 3D bioprinted pseudo-bone drug delivery scaffold for bone tissue engineering. Pharmaceutics2020; 12: 166.
29.
AmbekarRSKandasubramanianB. Progress in the advancement of porous biopolymer scaffold: tissue engineering application. Ind Eng Chem Res2019; 58: 6163–6194.
30.
SalamiMSBahramiGArkanE, et al. Co-electrospun nanofibrous mats loaded with bitter gourd (Momordica charantia) extract as the wound dressing materials: in vitro and in vivo study. BMC Complement Med Ther2021; 21: 1–12.
ZengQQiXShiG, et al. Wound dressing: from nanomaterials to diagnostic dressings and healing evaluations. ACS Nano2022; 16: 1708–1733.
33.
FarzamfarSAleahmadMGholamrezaS, et al. Polycaprolactone/gelatin nanofibrous scaffolds for tissue engineering. Biointerface Res Appl Chem2020; 11: 11104–11115.
34.
FarzamfarSEhteramiASalehiM, et al. Unrestricted somatic stem cells loaded in nanofibrous conduit as potential candidate for sciatic nerve regeneration. J Mol Neurosci2019; 67: 48–61.
35.
Rodriguez-GarciaAMacias-RodriguezYGonzalez-GonzalezJM. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis. Int Ophthalmol2018; 38: 1243–1249.
36.
MiZTofighiE. Lodoxamide-loaded nanofibrous wound dressings promote wound healing via downregulation of IL-1β, NFK-β, and GPx genes. J Biomed Nanotechnol2022; 18: 2392–2399.
37.
LazarusBMessinaABarkerJE, et al. The role of mast cells in ischaemia–reperfusion injury in murine skeletal muscle. J Pathol2000; 191: 443–448.
38.
KuroseIArgenbrightLWWolfR, et al. Ischemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators. Am J Physiol Heart Circ Physiol1997; 272: H2976–H2982.
39.
JangMBaeSJungY, et al. Enhanced wound healing using a 3D printed VEGF-mimicking peptide incorporated hydrogel patch in a pig model. Biomed Mater2021; 16: 045013.
40.
MarconiGDFonticoliLRajanTS, et al. Epithelial-mesenchymal transition (EMT): the type-2 EMT in wound healing, tissue regeneration and organ fibrosis. Cells2021; 10: 1587.
41.
Mathew-SteinerSSRoySSenCK. Collagen in wound healing. Bioengineering2021; 8: 63.
42.
Davison-KotlerEMarshallWSGarcía-GaretaE. Sources of collagen for biomaterials in skin wound healing. Bioengineering2019; 6: 56.
